Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT02278315 · COMPLETED
Trial details
- NCT number
- NCT02278315
- Sponsor
- Cellectar Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2020-12-09
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.